Latest Diamond Ranch Foods (PLPL) Headlines
Plandai Biotechnology buys remaining minority interest in Dunn Roman
M2 - Mon Mar 10, 8:02AM CDT
US-based plant extracts company Plandai Biotechnology (OTCQB
LPL) revealed on Friday the completion of the acquisition of another 18% ownership interest in Dunn Roman Holdings Africa (Pty).
Plandai Biotechnology Announces Acquisition of Minority Holders' Interest in South African Subsidiaries
Marketwire - Fri Mar 07, 11:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has acquired an additional eighteen percent (18%) ownership interest in Dunn Roman Holdings Africa (Pty) Ltd, the South African holding and management company that operates the Senteeko Tea Estate and the Phytofare(TM) production facility. With this acquisition, Plandai now owns 100% of Dunn Roman.
Legalizing Medical Marijuana Gaining More Momentum in Mid-Term Election Year
Marketwire - Thu Mar 06, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) is one of a handful of publicly traded companies that are eagerly anticipating the legalization of medical marijuana nationwide. Currently the drug is legal medicinally in 20 states and Washington, D.C., but in this election year, that number is likely to grow. In each national election year, the frenzy begins again and with it, a growing momentum that has the U.S. drawing closer to a nationwide acceptance.
Plandai Biotechnology: A Natural Fit Into the Marijuana Industry
Marketwire - Mon Mar 03, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) has a strong executive team in place, a well thought out business plan, and now it's time for the company to make its products the star. These products include Plandai's Phytofare(TM) botanical extracts such as its Green Tea Catechin Complex and the Limonoid Glycoside Complex, as well as a line of Diego Pellicer(R) medical cannabis products. It is the latter could make the company a leader in the marijuana industry.
Future of Plandai Biotechnology's Products in Good Hands With Former Microsoft Executive Heading Up Global Marketing
Marketwire - Tue Feb 25, 8:00AM CST
Today Plandai Biotechnology (OTCQB: PLPL) named former Microsoft executive Jamen Shively as the company's Vice President of Global Marketing. Shively has an extensive and impressive resume in the world of business, and the company is confident he can deliver Plandai's products on the world stage. According to Plandai, Shively will be responsible for building brand awareness and marketing strategy for all of the company's operations. Needless to say, they found just the right man for the future of their products.
Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing
Marketwire - Thu Feb 20, 8:03AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Plandai, has been named as Vice President of Global Marketing.
Recent Marijuana News From Washington, D.C., Pivotal to Plandai Biotechnology's Success in the Industry
Marketwire - Wed Feb 19, 8:03AM CST
Plandai Biotechnology (OTCQB: PLPL) executives are certainly in favor of what 18 legislators are trying to accomplish with their letter to President Obama asking him to reclassify marijuana. They're likely equally as elated with news from the Administration last Friday that paves the way for legal banking between legitimate marijuana businesses and U.S. banks.
Marijuana Entrepreneur Jamen Shively Goes Public With Plandai Biotechnology, Inc.
Marketwire - Fri Feb 14, 8:01AM CST
If Plandai Biotechnology (OTCQB: PLPL) investors liked the idea of Diego Pellicer co-founder Jamen Shively working with the company from the outside, then they'll love the idea that he's now on the inside of this public biotech. Jamen Shively, a former Microsoft executive turned marijuana entrepreneur, has gone public being named to the Board of Directors at Plandai.
Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively to Board of Directors
Marketwire - Thu Feb 13, 10:05AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has named Jamen Shively, a leading voice in the burgeoning marijuana industry and co-founder of the Diego Pellicer group of companies, to its Board of Directors. Mr. Shively will be filling the vacancy created with the resignation of David Rzepnicki, who recently resigned.
Plandai Biotechnology's Plan to Brand and Market Cannabis Extracts Boosted by $15.3 Million Funding Deal
Marketwire - Wed Feb 12, 9:11AM CST
Plandai Biotechnology (OTCQB: PLPL) has a real opportunity to be "first to market" with its Phytofare(TM) cannabis extracts, and it seems a new $15.3 million funding deal will go a long way to realizing that goal. The company's extracts will be used in both medical and pharmaceutical marijuana applications, and in what is either great business timing or a strong coincidence, Plandai completed the funding commitment only days after finalizing its branding deal with Diego Pellicer.
Plandai Biotechnology, Inc. Completes $15.3 Million Funding Commitment With Institutional Investor
Marketwire - Mon Feb 10, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor, whereby Lincoln Park committed to invest, at the Company's sole option, up to $15.3 million of equity capital over the term of the purchase agreement including an initial investment of $300,000.
IMD Companies, Inc., and ATM Enters Multi-Billion E-Cigarette Market with the Development of Virtualvaporbar.Com
PR Newswire - Mon Feb 10, 7:30AM CST
IMD Companies, Inc. (OTC:ICBU) and Anything Technologies Media Inc. (OTC:EXMT) are pleased to announce that their joint subsidiary GreenLink Inc., is in the final stages for the re-launch of Legalpot4sale.com. The business strategy of GreenLink Inc. is to appeal to buyers of legal marijuana who want access to reliable marijuana information on products and services, which can be accessed on their devices including tablets and phones.
Former Microsoft Exec Predicts Hundreds of Marijuana Stores Open in 5 Years: Plandai Biotechnology's (OTCQB: PLPL), AVT Inc. (OTCPINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Cannabis Science Inc. (NASDAQ OTC: CBIS)
ACCESSWIRE - Fri Feb 07, 11:50AM CST
Imagine your favorite shopping mall with its very own boutique marijuana store.
Plandai Biotechnology, Inc. Finalizes Acquisition of License to Diego Pellicer Brand for Medical & Pharmaceutical Marijuana Extracts
Marketwire - Fri Feb 07, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it closed the license agreement with Diego Pellicer, Inc. which will permit the company use of the Diego Pellicer name for its Phytofare(TM) cannabis extract in medical and pharmaceutical marijuana applications.
Plandai Biotechnology Learning Branding and Marketing From Former Microsoft Executive Turned Marijuana Entrepreneur
Marketwire - Thu Feb 06, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) is in good hands when it comes to the future of branding and marketing its Phytofare(TM) cannabis extracts for use in both medical and pharmaceutical marijuana applications. While Plandai continues to develop a full range of botanical extracts using its proprietary hydrodynamic sheering process, the company can follow the lead of its new branding partner, Diego Pellicer, Inc. and its co-founder Jamen Shively, to perfect a process as important as developing the extracts themselves -- marketing them.
Marijuana Entrepreneur Jamen Shively Discusses Plandai Biotechnology, Branding Cannabis, and Legalization
Marketwire - Tue Feb 04, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) recently entered into what could very well be the industry's biggest agreement to date. At the time, many investors may have viewed it as just another licensing agreement, but as Plandai lays the groundwork for its future, the deal with Diego Pellicer, Inc. and Diego Pellicer Worldwide permits the company to use the Diego Pellicer name for its Phytofare(TM) cannabis extracts. But, at the same time, it put Plandai in business with Jamen Shively, a former Microsoft executive and the co-founder of Diego Pellicer, Inc.
Plandai Biotechnology buys remaining minority interest in Dunn Roman
M2 - Mon Mar 10, 8:02AM CDT
US-based plant extracts company Plandai Biotechnology (OTCQB
LPL) revealed on Friday the completion of the acquisition of another 18% ownership interest in Dunn Roman Holdings Africa (Pty). Plandai Biotechnology Announces Acquisition of Minority Holders' Interest in South African Subsidiaries
Marketwire - Fri Mar 07, 11:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has acquired an additional eighteen percent (18%) ownership interest in Dunn Roman Holdings Africa (Pty) Ltd, the South African holding and management company that operates the Senteeko Tea Estate and the Phytofare(TM) production facility. With this acquisition, Plandai now owns 100% of Dunn Roman.
Legalizing Medical Marijuana Gaining More Momentum in Mid-Term Election Year
Marketwire - Thu Mar 06, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) is one of a handful of publicly traded companies that are eagerly anticipating the legalization of medical marijuana nationwide. Currently the drug is legal medicinally in 20 states and Washington, D.C., but in this election year, that number is likely to grow. In each national election year, the frenzy begins again and with it, a growing momentum that has the U.S. drawing closer to a nationwide acceptance.
Plandai Biotechnology: A Natural Fit Into the Marijuana Industry
Marketwire - Mon Mar 03, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) has a strong executive team in place, a well thought out business plan, and now it's time for the company to make its products the star. These products include Plandai's Phytofare(TM) botanical extracts such as its Green Tea Catechin Complex and the Limonoid Glycoside Complex, as well as a line of Diego Pellicer(R) medical cannabis products. It is the latter could make the company a leader in the marijuana industry.
Future of Plandai Biotechnology's Products in Good Hands With Former Microsoft Executive Heading Up Global Marketing
Marketwire - Tue Feb 25, 8:00AM CST
Today Plandai Biotechnology (OTCQB: PLPL) named former Microsoft executive Jamen Shively as the company's Vice President of Global Marketing. Shively has an extensive and impressive resume in the world of business, and the company is confident he can deliver Plandai's products on the world stage. According to Plandai, Shively will be responsible for building brand awareness and marketing strategy for all of the company's operations. Needless to say, they found just the right man for the future of their products.
Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing
Marketwire - Thu Feb 20, 8:03AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Plandai, has been named as Vice President of Global Marketing.
Recent Marijuana News From Washington, D.C., Pivotal to Plandai Biotechnology's Success in the Industry
Marketwire - Wed Feb 19, 8:03AM CST
Plandai Biotechnology (OTCQB: PLPL) executives are certainly in favor of what 18 legislators are trying to accomplish with their letter to President Obama asking him to reclassify marijuana. They're likely equally as elated with news from the Administration last Friday that paves the way for legal banking between legitimate marijuana businesses and U.S. banks.
Marijuana Entrepreneur Jamen Shively Goes Public With Plandai Biotechnology, Inc.
Marketwire - Fri Feb 14, 8:01AM CST
If Plandai Biotechnology (OTCQB: PLPL) investors liked the idea of Diego Pellicer co-founder Jamen Shively working with the company from the outside, then they'll love the idea that he's now on the inside of this public biotech. Jamen Shively, a former Microsoft executive turned marijuana entrepreneur, has gone public being named to the Board of Directors at Plandai.
Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively to Board of Directors
Marketwire - Thu Feb 13, 10:05AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has named Jamen Shively, a leading voice in the burgeoning marijuana industry and co-founder of the Diego Pellicer group of companies, to its Board of Directors. Mr. Shively will be filling the vacancy created with the resignation of David Rzepnicki, who recently resigned.
Plandai Biotechnology's Plan to Brand and Market Cannabis Extracts Boosted by $15.3 Million Funding Deal
Marketwire - Wed Feb 12, 9:11AM CST
Plandai Biotechnology (OTCQB: PLPL) has a real opportunity to be "first to market" with its Phytofare(TM) cannabis extracts, and it seems a new $15.3 million funding deal will go a long way to realizing that goal. The company's extracts will be used in both medical and pharmaceutical marijuana applications, and in what is either great business timing or a strong coincidence, Plandai completed the funding commitment only days after finalizing its branding deal with Diego Pellicer.
Plandai Biotechnology, Inc. Completes $15.3 Million Funding Commitment With Institutional Investor
Marketwire - Mon Feb 10, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor, whereby Lincoln Park committed to invest, at the Company's sole option, up to $15.3 million of equity capital over the term of the purchase agreement including an initial investment of $300,000.
IMD Companies, Inc., and ATM Enters Multi-Billion E-Cigarette Market with the Development of Virtualvaporbar.Com
PR Newswire - Mon Feb 10, 7:30AM CST
IMD Companies, Inc. (OTC:ICBU) and Anything Technologies Media Inc. (OTC:EXMT) are pleased to announce that their joint subsidiary GreenLink Inc., is in the final stages for the re-launch of Legalpot4sale.com. The business strategy of GreenLink Inc. is to appeal to buyers of legal marijuana who want access to reliable marijuana information on products and services, which can be accessed on their devices including tablets and phones.
Former Microsoft Exec Predicts Hundreds of Marijuana Stores Open in 5 Years: Plandai Biotechnology's (OTCQB: PLPL), AVT Inc. (OTCPINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Cannabis Science Inc. (NASDAQ OTC: CBIS)
ACCESSWIRE - Fri Feb 07, 11:50AM CST
Imagine your favorite shopping mall with its very own boutique marijuana store.
Plandai Biotechnology, Inc. Finalizes Acquisition of License to Diego Pellicer Brand for Medical & Pharmaceutical Marijuana Extracts
Marketwire - Fri Feb 07, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it closed the license agreement with Diego Pellicer, Inc. which will permit the company use of the Diego Pellicer name for its Phytofare(TM) cannabis extract in medical and pharmaceutical marijuana applications.
Plandai Biotechnology Learning Branding and Marketing From Former Microsoft Executive Turned Marijuana Entrepreneur
Marketwire - Thu Feb 06, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) is in good hands when it comes to the future of branding and marketing its Phytofare(TM) cannabis extracts for use in both medical and pharmaceutical marijuana applications. While Plandai continues to develop a full range of botanical extracts using its proprietary hydrodynamic sheering process, the company can follow the lead of its new branding partner, Diego Pellicer, Inc. and its co-founder Jamen Shively, to perfect a process as important as developing the extracts themselves -- marketing them.
Marijuana Entrepreneur Jamen Shively Discusses Plandai Biotechnology, Branding Cannabis, and Legalization
Marketwire - Tue Feb 04, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) recently entered into what could very well be the industry's biggest agreement to date. At the time, many investors may have viewed it as just another licensing agreement, but as Plandai lays the groundwork for its future, the deal with Diego Pellicer, Inc. and Diego Pellicer Worldwide permits the company to use the Diego Pellicer name for its Phytofare(TM) cannabis extracts. But, at the same time, it put Plandai in business with Jamen Shively, a former Microsoft executive and the co-founder of Diego Pellicer, Inc.
